{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T06:40:10Z","timestamp":1775544010969,"version":"3.50.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1053\/j.gastro.2015.02.038","type":"journal-article","created":{"date-parts":[[2015,2,24]],"date-time":"2015-02-24T14:34:22Z","timestamp":1424788462000},"page":"701-704","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Topical Therapy in Ulcerative Colitis: Always a Bridesmaid but Never a Bride?"],"prefix":"10.1053","volume":"148","author":[{"given":"Subrata","family":"Ghosh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Daperno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2015.02.038_bib1","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1080\/00365520802600961","article-title":"Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN study)","volume":"44","author":"Solberg","year":"2009","journal-title":"Scand J Gastroenterology"},{"key":"10.1053\/j.gastro.2015.02.038_bib2","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.crohns.2013.08.007","article-title":"Combined oral and rectal mesalazine for the treatment of mild-to-moderately active ulcerative colitis: rapid symptom resolution and improvements in quality of life","volume":"8","author":"Probert","year":"2014","journal-title":"J\u00a0Crohn\u2019s Colitis"},{"key":"10.1053\/j.gastro.2015.02.038_bib3","first-page":"1867","article-title":"A\u00a0double-blind comparison of oral versus rectal mesalamine versus combination therapy in the treatment of distal ulcerative colitis","volume":"92","author":"Safdi","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2015.02.038_bib4","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/gut.2004.060103","article-title":"Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild\/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study","volume":"54","author":"Marteau","year":"2005","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2015.02.038_bib5","doi-asserted-by":"crossref","first-page":"71S","DOI":"10.1007\/BF01312468","article-title":"Double-blind, placebo-controlled evaluation of 5-ASA suppositories in active proctitis and measurement of extent of spread using 99m-Tc labelled 5-ASA suppositories","volume":"72","author":"William","year":"1987","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2015.02.038_bib6","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/01.mib.0000231495.92013.5e","article-title":"Medical management of left-sided ulcerative colitis and ulcerative proctitis: critical evaluation of therapeutic trials","volume":"12","author":"Regueiro","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2015.02.038_bib7","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.cgh.2013.10.019","article-title":"Evaluation of the patient-reported outcomes measurement information system in a large cohort of patients with inflammatory bowel diseases","volume":"12","author":"Kappelman","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2015.02.038_bib8","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.cgh.2014.02.016","article-title":"Patient-reported outcomes as primary end points in clinical trials of inflammatory bowel disease","volume":"12","author":"Williet","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2015.02.038_bib9","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.crohns.2013.03.005","article-title":"Topical therapy is underused in patients with ulcerative colitis","volume":"8","author":"Siebold","year":"2014","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2015.02.038_bib10","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1572-0241.2005.40849.x","article-title":"Are patients with inflammatory bowel disease receiving optimum care?","volume":"100","author":"Reddy","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2015.02.038_bib11","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2036.2006.02743.x","article-title":"Budesonide foam versus budesonide enema in active ulcerative proctitis and proctosigmoiditis","volume":"23","author":"Gross","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2015.02.038_bib12","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s10350-004-6687-x","article-title":"Budesonide foam vs. hydrocortisone acetate foam in the treatment of active ulcerative proctosigmoiditis","volume":"46","author":"Bar-Meir","year":"2003","journal-title":"Dis Colon Rectum"},{"key":"10.1053\/j.gastro.2015.02.038_bib13","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1365-2036.2010.04354.x","article-title":"Clinical trial: Controlled, open, randomized multicenter study comparing the effects of treatment on quality of life, safety and efficacy of budesonide or mesalazine enemas in active, left-sided ulcerative colitis","volume":"32","author":"Hartman","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2015.02.038_bib14","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1053\/j.gastro.2015.01.037","article-title":"Budesonide foam induces remission in patients with mild to moderate ulcerative proctitis and ulcerative proctosigmoiditis","volume":"148","author":"Sandborn","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2015.02.038_bib15","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.crohns.2007.11.002","article-title":"European evidence based consensus on the management of ulcerative colitis: current management","volume":"2","author":"Travis","year":"2008","journal-title":"J\u00a0Crohn\u2019s Colitis"},{"key":"10.1053\/j.gastro.2015.02.038_bib16","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.crohns.2012.09.002","article-title":"Second European evidence-based consensus on the diagnosis and management of ulcerative colitis: current management","volume":"6","author":"Dignass","year":"2012","journal-title":"J\u00a0Crohn\u2019s Colitis"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508515002607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508515002607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T15:11:21Z","timestamp":1758035481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508515002607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0016508515002607"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2015.02.038","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topical Therapy in Ulcerative Colitis: Always a Bridesmaid but Never a Bride?","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2015.02.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2015.01.037","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 AGA Institute. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}